The Future Healthcare Challenge Turkey meets you with an extraordinary fair in Istanbul

The Future Healthcare Turkey 2019 is the most ambitious meeting point of the region, you may introduce your advanced healthcare solutions and technologies to VIP BUYERS in this rapidly increasing sector and can express yourself in panels.

During The Future Healthcare Turkey 2019 you can reach all kinds of high quality products, suppliers, investors, customers, decision makers related to healthcare; perform purchases, sales and agreements.

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

CHMP Recommends Approval of Dupixent for Severe Chronic Rhinosinusitis with Nasal Polyposis

Incyte Announces First Patient Treated in Phase 3 Clinical Trial Program Evaluating Ruxolitinib Cream in Patients with Vitiligo

iOmx Therapeutics Announces Discovery of Novel, Druggable Immune-Checkpoint Targets

Vineti and Cryoport Collaborate to Bring Integrated Solutions to the Global Regenerative Therapy Market

Catalent To Open New Clinical Supply Facility In San Diego

Roxadustat approved in China for the treatment of anaemia in non-dialysis-dependent patients with chronic kidney disease

Rentschler Fill Solutions receives open-ended GMP certification by the Austrian authority AGES

ADC Therapeutics and Freenome Enter Biomarker Development Collaboration

DiscGenics Receives FDA Fast Track Designation for Cell Therapy for Disc Degeneration

CHMP Recommends Approval of Dupixent for Severe Chronic Rhinosinusitis with Nasal Polyposis

Incyte Announces First Patient Treated in Phase 3 Clinical Trial Program Evaluating Ruxolitinib Cream in Patients with Vitiligo

iOmx Therapeutics Announces Discovery of Novel, Druggable Immune-Checkpoint Targets

Vineti and Cryoport Collaborate to Bring Integrated Solutions to the Global Regenerative Therapy Market

Catalent To Open New Clinical Supply Facility In San Diego

Roxadustat approved in China for the treatment of anaemia in non-dialysis-dependent patients with chronic kidney disease

Rentschler Fill Solutions receives open-ended GMP certification by the Austrian authority AGES

ADC Therapeutics and Freenome Enter Biomarker Development Collaboration

DiscGenics Receives FDA Fast Track Designation for Cell Therapy for Disc Degeneration

The Future Healthcare Challenge Turkey meets you with an extraordinary fair in Istanbul

Arena Reports Second Quarter Financial Results with Strong Liquidity Position and Olorinab CAPTIVATE Trials

Dynacure Receives Orphan Drug Designation from the US FDA for DYN101 an Antisense Medicine to Treat Rare Disease Centronuclear Myopathies

Related Posts

Cryoport Introduces Cell Gene Industrys First Dedicated Shipper for Advanced Therapies

Air France KLM Martinair Cargo becomes first major airline group to be IATA CEIV Pharma re-certifie

Pfizer and Flatiron Health Announce Expanded Strategic Collaboration to Unlock Power of Real-World Evidence in Oncology

iOmx Therapeutics Announces Discovery of Novel, Druggable Immune-Checkpoint Targets

VNUE AP, hand in hand with TCELS and the Science and Technology Trade Association,to organize Thailand LAB INTERNATIONAL and Bio Investment Asia 2019

Sonoco ThermoSafe Introduces the Pegasus ULD line of Passive Temperature Controlled Unit Load Devices

Dynacure Receives Orphan Drug Designation from the US FDA for DYN101 an Antisense Medicine to Treat Rare Disease Centronuclear Myopathies

Latest News

CHMP Recommends Approval of Dupixent for Severe Chronic Rhinosinusitis with Nasal Polyposis

Constellation Pharmaceuticals Advances CPI-0209 into Clinical Trials, Expanding its EZH2 Franchise

Cryoport Introduces Cell Gene Industrys First Dedicated Shipper for Advanced Therapies

Air France KLM Martinair Cargo becomes first major airline group to be IATA CEIV Pharma re-certifie

Incyte Announces First Patient Treated in Phase 3 Clinical Trial Program Evaluating Ruxolitinib Cream in Patients with Vitiligo

About Us

Qucik Links

Resources

System

Retrieve your password